Domov › Alzheimerjeva bolezen › Florida › Orlando

Klinične študije za Alzheimerjeva bolezen v Orlando, FL

25 študij za Alzheimerjeva bolezen išče udeležence na lokacijah v Orlando in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

Vključevanje udeležencevFaza 2

Clinical Site, Orlando

Starost 55–90 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT06887192

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

Vključevanje udeležencevFaza 2

K2 Medical Research, Maitland · 6 mi stran

Starost 55 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT06540833

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

Vključevanje udeležencevFaza 3

Local Institution - 1635, Orlando

Starost 55–90 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT06937229

A Study of LY3439539 in Participants With Alzheimer's Disease

Vključevanje udeležencevFaza 1

Charter Research, Orlando
AdventHealth Orlando, Orlando
K2 Medical Research, Maitland · 6 mi stran

Starost 50–85 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT07598370

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Vključevanje udeležencevFaza 3

Charter Research Orlando, Orlando
Nova Psychiatry, Orlando
Combined Research Orlando Phase I-IV LLC, Orlando
in še 1

Starost 55–90 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06585787

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

Vključevanje udeležencevFaza 2

Charter Research - Orlando, Orlando
Conquest Research, Winter Park · 5 mi stran
K2 Medical Research ORLANDO, Maitland · 6 mi stran

Starost 55–85 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07589595

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

Vključevanje udeležencevFaza 2

Conquest Research - Lake Nona, Orlando

Starost 55–80 · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT06847321

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Vključevanje udeležencevFaza 3

Charter Research - Winter Park/Orlando, Orlando
Conquest Research - Lake Nona, Orlando
Conquest Research, LLC, Winter Park · 5 mi stran
in še 2

Starost 50–90 · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT07177352

A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease

Vključevanje udeležencevFaza 1/2

Conquest Research - Winter Park /ID# 277760, Winter Park · 5 mi stran
K2 Medical Research - Clermont /ID# 277859, Clermont · 24 mi stran

Starost 50–90 · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT07599670

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

Vključevanje udeležencevFaza 3

Combined Research Orlando (CRO), Orlando
Local Institution - 1622, Maitland · 6 mi stran
Local Institution - 1631, Maitland · 6 mi stran

Starost 55–90 · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07011732

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

Vključevanje udeležencevFaza 3

Local Institution - 2634, Orlando

Starost 55–90 · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07011745

A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

Vključevanje udeležencevFaza 3

K2 Medical Research, LLC, Maitland · 6 mi stran

Starost 55–80 · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT07717411

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

Vključevanje udeležencevFaza 2

ClinCloud, Maitland · 6 mi stran
Local Institution - 0007, Maitland · 6 mi stran

Starost 55–90 · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT06808984

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

Vključevanje udeležencevFaza 2

Charter Research - Orlando ( Site 1051), Orlando
Conquest Research LLC ( Site 1053), Winter Park · 5 mi stran
K2 Medical Research ( Site 1047), Maitland · 6 mi stran

Starost 50–85 · Vsi spoli · Posodobljeno 26. avg. 2026 · NCT07033494

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

Vključevanje udeležencevFaza 1

K2 Medical Research, LLC, Maitland · 6 mi stran

Starost 50–85 · Vsi spoli · Posodobljeno 24. avg. 2026 · NCT06297590

A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

Vključevanje udeležencevFaza 1/2

Charter Research, LLC, Orlando
Headlands Horizons LLC, Orlando

Starost 35–85 · Vsi spoli · Posodobljeno 10. jul. 2026 · NCT05462106

Low-Dose Radiotherapy for Alzheimer's Disease

Vključevanje udeležencevFaza 1/2

Renaissance Institute of Precision Oncology & Radiosurgery, Winter Park · 5 mi stran

Starost 50 in več · Vsi spoli · Posodobljeno 9. jul. 2026 · NCT07693140

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

Vključevanje udeležencevFaza 3

Charter Research - Orlando, Orlando
Headlands Research Orlando, Orlando
Conquest Research, Winter Park · 5 mi stran
in še 1

Starost 55 in več · Vsi spoli · Posodobljeno 7. jul. 2026 · NCT07602582

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

Vključevanje udeležencevFaza 2

Conquest Research, Winter Park · 5 mi stran
K2 Medical Research LLC, Maitland · 6 mi stran
K2 Medical Research LLC, Maitland · 6 mi stran

Starost 50–85 · Vsi spoli · Posodobljeno 26. jun. 2026 · NCT07094516

A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)

Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci

K2 Medical Research, Maitland · 6 mi stran

Starost 45–85 · Vsi spoli · Posodobljeno 4. jun. 2026 · NCT06657768

[18F]PI-2620 Phase 3 Histopathological Study

Vključevanje udeležencevFaza 3

Charter Research, Winter Park · 5 mi stran
K2 Medical Research, Maitland · 6 mi stran

Starost 50 in več · Vsi spoli · Posodobljeno 22. maj 2026 · NCT05641688

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Charter Research, Orlando
Conquest Research, Winter Park · 5 mi stran
K2 Medical Research, Maitland · 6 mi stran
in še 1

Starost 60–90 · Vsi spoli · Posodobljeno 15. apr. 2026 · NCT06584357

Open-label Extension Study in Participants With Early Alzheimer's Disease

Vključevanje udeležencevFaza 2

GSK Investigational Site, Maitland · 6 mi stran

Starost 50–85 · Vsi spoli · Posodobljeno 2. feb. 2026 · NCT07105709

ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

Vključevanje udeležencev

Advent Health, Orlando

Starost 50–85 · Vsi spoli · Posodobljeno 9. jan. 2026 · NCT03671889

University of Central Florida CereBank

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

University of Central Florida, Orlando

Starost 18 in več · Ženske · Posodobljeno 14. mar. 2025 · NCT06876857

Študije za Alzheimerjeva bolezen v drugih mestih

Druge študije v Orlando

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.